• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥术中辅酶Q10对心肌再灌注损伤的保护作用。

Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting.

作者信息

Chello M, Mastroroberto P, Romano R, Bevacqua E, Pantaleo D, Ascione R, Marchese A R, Spampinato N

机构信息

Department of Cardiac Surgery, Medical School of Catanzaro, Italy.

出版信息

Ann Thorac Surg. 1994 Nov;58(5):1427-32. doi: 10.1016/0003-4975(94)91928-3.

DOI:10.1016/0003-4975(94)91928-3
PMID:7979670
Abstract

To evaluate the effect of coenzyme Q10 in reducing postoperative cardiac complications after ischemia and reperfusion, we randomly divided 40 patients undergoing elective coronary artery bypass into two groups: patients in group 1 received coenzyme Q10 (150 mg/day) for 7 days before operation, and those in group 2 were the control group. Concentrations of thiobarbituric acid-reactive substances (malondialdehyde), conjugated dienes, and cardiac isoenzymes of creatine kinase were measured in samples from both arterial and coronary sinus sites. Serial sampling was performed 5 minutes after heparin administration, at 10 and 30 minutes during cardiopulmonary bypass, 15 and 30 minutes after aortic cross-clamp removal, and 5 minutes after protamine administration. The concentrations of malondialdehyde, conjugated dienes, and creatine kinase in group 1 were significantly lower than those in group 2. The decrease in plasma malondialdehyde concentrations correlated positively with the decrease in creatine kinase levels in the coronary sinus. The treatment group showed a significantly lower incidence of ventricular arrhythmias during the recovery period than did the control group (p < 0.05). Although the percentage of patients requiring inotropic agents was not significantly different between the two groups, the mean dosage of dopamine required to maintain stable hemodynamics was significantly lower in patients of group 1 than in those of group 2 (p < 0.01). Our findings suggest that pretreatment with coenzyme Q10 may play a protective role during routine bypass grafting by attenuating the degree of peroxidative damage.

摘要

为评估辅酶Q10在减少缺血再灌注后术后心脏并发症方面的作用,我们将40例行择期冠状动脉搭桥术的患者随机分为两组:第1组患者在术前7天接受辅酶Q10(150毫克/天)治疗,第2组为对照组。在动脉和冠状窦部位采集的样本中测量硫代巴比妥酸反应性物质(丙二醛)、共轭二烯和肌酸激酶心脏同工酶的浓度。在肝素给药后5分钟、体外循环期间10分钟和30分钟、主动脉阻断钳移除后15分钟和30分钟以及鱼精蛋白给药后5分钟进行系列采样。第1组中丙二醛、共轭二烯和肌酸激酶的浓度显著低于第2组。血浆丙二醛浓度的降低与冠状窦中肌酸激酶水平的降低呈正相关。治疗组在恢复期室性心律失常的发生率显著低于对照组(p<0.05)。虽然两组中需要使用正性肌力药物的患者百分比没有显著差异,但第1组患者维持稳定血流动力学所需多巴胺的平均剂量显著低于第2组患者(p<0.01)。我们的研究结果表明,术前使用辅酶Q10可能通过减轻过氧化损伤程度在常规搭桥手术中发挥保护作用。

相似文献

1
Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting.冠状动脉搭桥术中辅酶Q10对心肌再灌注损伤的保护作用。
Ann Thorac Surg. 1994 Nov;58(5):1427-32. doi: 10.1016/0003-4975(94)91928-3.
2
Protection by coenzyme Q10 of tissue reperfusion injury during abdominal aortic cross-clamping.
J Cardiovasc Surg (Torino). 1996 Jun;37(3):229-35.
3
Studies of hypoxemic/reoxygenation injury: without aortic clamping. VII. Counteraction of oxidant damage by exogenous antioxidants: coenzyme Q10.低氧血症/再氧合损伤的研究:无主动脉夹闭。VII. 外源性抗氧化剂对氧化损伤的对抗作用:辅酶Q10。
J Thorac Cardiovasc Surg. 1995 Oct;110(4 Pt 2):1221-7. doi: 10.1016/s0022-5223(95)70008-0.
4
Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment.辅酶Q10预处理改善心脏对缺血耐受性的三方机制解析。
J Thorac Cardiovasc Surg. 1996 Feb;111(2):443-50. doi: 10.1016/s0022-5223(96)70455-5.
5
Effects of coenzyme Q10 added to a potassium cardioplegic solution for myocardial protection during ischemic cardiac arrest.
Ann Thorac Surg. 1985 Jan;39(1):30-6. doi: 10.1016/s0003-4975(10)62519-2.
6
Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization.辅酶Q10增强冠状动脉血运重建术中心肌保护作用的临床经验
Cardiovasc Drugs Ther. 1991 Mar;5 Suppl 2:297-300. doi: 10.1007/BF00054751.
7
The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.白细胞去除血停搏液对重度左心室功能不全患者的影响:一项随机双盲研究。
J Thorac Cardiovasc Surg. 2000 Oct;120(4):642-50. doi: 10.1067/mtc.2000.109707.
8
Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting.择期冠状动脉搭桥手术患者中硝苯地平与硝苯地平联合美托洛尔围手术期心肌保护作用的比较
J Thorac Cardiovasc Surg. 1995 Nov;110(5):1461-9. doi: 10.1016/S0022-5223(95)70069-2.
9
Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting.冠状动脉搭桥手术期间的脂质过氧化及维生素E水平变化。
J Thorac Cardiovasc Surg. 1993 Aug;106(2):268-74.
10
Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients.冠状动脉搭桥术患者中缺血再灌注损伤与术后梗死相分离的证明。
Ann Thorac Surg. 1998 Jan;65(1):48-53. doi: 10.1016/s0003-4975(97)01036-9.

引用本文的文献

1
Therapeutic strategies to ameliorate mitochondrial oxidative stress in ischaemia-reperfusion injury: A narrative review.改善缺血再灌注损伤中线粒体氧化应激的治疗策略:一项叙述性综述。
Clin Sci (Lond). 2025 Feb 3;139(3):CS20242074. doi: 10.1042/CS20242074.
2
Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality.辅酶 Q10(泛醌)与还原型辅酶 Q10(泛醇)作为预防心血管疾病和降低心血管死亡率的补充剂的比较。
Curr Cardiol Rep. 2023 Dec;25(12):1759-1767. doi: 10.1007/s11886-023-01992-6. Epub 2023 Nov 16.
3
Coenzyme Q Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms.
辅酶Q减少心肌缺血-再灌注损伤动物模型中的梗死面积:一项荟萃分析及潜在机制总结
Front Cardiovasc Med. 2022 Apr 15;9:857364. doi: 10.3389/fcvm.2022.857364. eCollection 2022.
4
Combating Ischemia-Reperfusion Injury with Micronutrients and Natural Compounds during Solid Organ Transplantation: Data of Clinical Trials and Lessons of Preclinical Findings.在实体器官移植中使用微量营养素和天然化合物防治缺血再灌注损伤:临床试验数据和临床前研究结果的经验教训。
Int J Mol Sci. 2021 Oct 1;22(19):10675. doi: 10.3390/ijms221910675.
5
Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem.辅酶Q10在心血管和代谢疾病中的应用:问题现状
Curr Cardiol Rev. 2018;14(3):164-174. doi: 10.2174/1573403X14666180416115428.
6
The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.无创心血管检测、应用临床营养及营养补充剂在冠心病防治中的作用。
Ther Adv Cardiovasc Dis. 2018 Mar;12(3):85-108. doi: 10.1177/1753944717743920. Epub 2018 Jan 10.
7
Nutritional and vitamin supplements: do they prevent coronary artery disease?营养及维生素补充剂:它们能预防冠状动脉疾病吗?
Mo Med. 2012 May-Jun;109(3):204-9.
8
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.他汀类药物的不良反应:文献综述及线粒体机制证据
Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.
9
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction.载辅酶Q10脂质体对急性实验性心肌梗死家兔心肌的保护作用。
Pharm Res. 2007 Nov;24(11):2131-7. doi: 10.1007/s11095-007-9334-0. Epub 2007 Jul 27.
10
Pathobiology and Clinical Impact of Reperfusion Injury.再灌注损伤的病理生物学及临床影响
J Thromb Thrombolysis. 1997;4(2):185-195. doi: 10.1023/a:1008866111951.